Hui Shen
Molecular Biology · Cell · 2010–2018
A researcher in the Science corpus: 33 papers; trusts 9 researchers and is trusted by 3 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 685 citations into it; #10,531 of 17,773 by trust here, #448 by citations
- Genetics — 303 citations into it
- Evaluation & Benchmarks — 9 citations into it
Whom Hui Shen trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Hui Shen overall
Papers from Hui Shen's perspective
Ordered by how strongly the researchers Hui Shen trusts endorse each paper. Same corpus, a different order for every researcher.
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers (Genome Biology)
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer (New England Journal of Medicine)
- Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses (Science)
- COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
- A method and server for predicting damaging missense mutations
- IDH1 and IDH2 mutations in gliomas. (New England Journal of Medicine)
- High density DNA methylation array with single CpG site resolution. (Genomics)
- Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk (Science)
- ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking (Bioinform.)
- Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines (Cell Systems)
Their papers
- Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. (2010) — 2,267 citations
- Comprehensive molecular portraits of human breast tumors (2012) — 7,518 citations
- Comprehensive Molecular Characterization of Human Colon and Rectal Cancer (2012) — 7,754 citations
- Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. (2010) — 867 citations
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- Discovery of multi-dimensional modules by integrative analysis of cancer genomic data (2012) — 330 citations
- Integrated Genomic Analyses of Ovarian Carcinoma (2011) — 7,559 citations
- Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma (2016) — 1,926 citations
- Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas (2018) — 959 citations
- Comprehensive analyses of tumor immunity: implications for cancer immunotherapy (2016) — 2,015 citations
- Interplay between the cancer genome and epigenome. (2013) — 842 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma (2017) — 2,216 citations
- Comprehensive characterization, annotation and innovative use of Infinium DNA methylation BeadChip probes (2016) — 750 citations
- Comprehensive Molecular Characterization of Urothelial Bladder Carcinoma (2014) — 2,001 citations
- Comprehensive Molecular Characterization of Papillary Renal Cell Carcinoma (2015) — 1,150 citations
- Pathogenic germline variants in 10,389 adult cancers (2018) — 734 citations
- The Immune Landscape of Cancer (2018) — 4,752 citations
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) — 2,663 citations
- Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas (2018)